{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T15:21:44Z","timestamp":1778340104489,"version":"3.51.4"},"reference-count":50,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Reproductive BioMedicine Online"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.rbmo.2011.10.010","type":"journal-article","created":{"date-parts":[[2011,10,31]],"date-time":"2011-10-31T09:38:35Z","timestamp":1320053915000},"page":"197-205","source":"Crossref","is-referenced-by-count":37,"title":["Apolipoprotein E-containing HDL-associated platelet-activating factor acetylhydrolase activities and malondialdehyde concentrations in patients with PCOS"],"prefix":"10.1016","volume":"24","author":[{"given":"Ping","family":"Fan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huai","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rbmo.2011.10.010_b0005","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0022-2275(20)32032-0","article-title":"Preparative free-solution isotachophoresis for separation of human plasma lipoproteins: apolipoprotein and lipid composition of HDL subfractions","volume":"41","author":"Bottcher","year":"2000","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.rbmo.2011.10.010_b0010","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00041433-200308000-00002","article-title":"Lipoprotein-associated phospholipase A2 (platelet-activating factor acetylhydrolase) and cardiovascular disease","volume":"14","author":"Caslake","year":"2003","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.rbmo.2011.10.010_b0015","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1590\/S0074-02762005000900014","article-title":"Regulating inflammation through the anti-inflammatory enzyme platelet-activating factor-acetylhydrolase","volume":"100","author":"Castro Faria Neto","year":"2005","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.rbmo.2011.10.010_b0020","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00041433-200406000-00015","article-title":"Platelet-activating factor acetylhydrolase: is it good or bad for you?","volume":"15","author":"Chen","year":"2004","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.rbmo.2011.10.010_b0025","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0885-4505(92)90005-J","article-title":"A rapid and simple quantification of human apolipoprotein E-rich high-density lipoproteins in serum","volume":"47","author":"Chiba","year":"1992","journal-title":"Biochem. Med. Metab. Biol."},{"key":"10.1016\/j.rbmo.2011.10.010_b0030","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0022-2275(20)38312-7","article-title":"Binding of apoE-rich high density lipoprotein particles by saturable sites on human blood platelets inhibits agonist-induced platelet aggregation","volume":"30","author":"Desai","year":"1989","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.rbmo.2011.10.010_b0035","first-page":"140","article-title":"Insulin resistance, insulin sensitization and inflammation in polycystic ovarian syndrome","volume":"50","author":"Dhindsa","year":"2004","journal-title":"J. Postgrad. Med."},{"key":"10.1016\/j.rbmo.2011.10.010_b0040","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1093\/humrep\/del003","article-title":"Indices of low-grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metformin","volume":"21","author":"Diamanti-Kandarakis","year":"2006","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2011.10.010_b0045","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1055\/s-2007-992923","article-title":"Cardiovascular disease risk factors in polycystic ovary syndrome","volume":"26","author":"Dokras","year":"2008","journal-title":"Semin. Reprod. Med."},{"key":"10.1016\/j.rbmo.2011.10.010_b0050","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1093\/humrep\/deh299","article-title":"Proliferation of ovarian theca-interstitial cells is modulated by antioxidants and oxidative stress","volume":"19","author":"Duleba","year":"2004","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2011.10.010_b0055","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1007\/BF03345614","article-title":"The relationship of the interleukin-6-174 G>C gene polymorphism with oxidative stress markers in Turkish polycystic ovary syndrome patients","volume":"31","author":"Erdogan","year":"2008","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.rbmo.2011.10.010_b0060","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1089\/ars.2005.7.1040","article-title":"The molecular basis for oxidative stress-induced insulin resistance","volume":"7","author":"Evans","year":"2005","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.rbmo.2011.10.010_b0065","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1016\/j.fertnstert.2009.06.022","article-title":"Altered distribution of plasma platelet-activating factor acetylhydrolase between high-density lipoprotein and low-density lipoprotein in patients with polycystic ovary syndrome","volume":"92","author":"Fan","year":"2009","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2011.10.010_b0070","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1093\/humrep\/deq047","article-title":"Identification of the G994T polymorphism in exon 9 of plasma platelet-activating factor acetylhydrolase gene as a risk factor for polycystic ovary syndrome","volume":"25","author":"Fan","year":"2010","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2011.10.010_b0075","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199509283331307","article-title":"Polycystic ovary syndrome","volume":"333","author":"Franks","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.rbmo.2011.10.010_b0080","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1373\/clinchem.2005.058404","article-title":"Lipoprotein-associated phospholipase A2 activity is a marker of small, dense LDL particles in human plasma","volume":"51","author":"Gazi","year":"2005","journal-title":"Clin. Chem."},{"key":"10.1016\/j.rbmo.2011.10.010_b0085","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1210\/jc.2005-1696","article-title":"Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome","volume":"91","author":"Gonzalez","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.rbmo.2011.10.010_b0090","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1055\/s-2007-992919","article-title":"Looking for polycystic ovary syndrome genes: rational and best strategy","volume":"26","author":"Goodarzi","year":"2008","journal-title":"Semin. Reprod. Med."},{"key":"10.1016\/j.rbmo.2011.10.010_b0095","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.bpobgyn.2004.05.001","article-title":"Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome","volume":"18","author":"Hart","year":"2004","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"10.1016\/j.rbmo.2011.10.010_b0100","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1161\/01.ATV.0000201282.64751.47","article-title":"Apolipoprotein E recycling: implications for dyslipidemia and atherosclerosis","volume":"26","author":"Heeren","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.rbmo.2011.10.010_b0105","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.fertnstert.2009.03.005","article-title":"Can serum apolipoprotein C-I demonstrate metabolic abnormality early in women with polycystic ovary syndrome?","volume":"94","author":"Huang","year":"2010","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2011.10.010_b0110","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.bbalip.2006.06.017","article-title":"Clinical aspects of plasma platelet-activating factor-acetylhydrolase","volume":"1761","author":"Karasawa","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.rbmo.2011.10.010_b0115","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.2165\/00003495-200868130-00001","article-title":"HMG-CoA reductase inhibitors: do they have potential in the treatment of polycystic ovary syndrome?","volume":"68","author":"Kodaman","year":"2008","journal-title":"Drugs"},{"key":"10.1016\/j.rbmo.2011.10.010_b0125","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0022-2275(20)37273-4","article-title":"Characterization of human plasma apolipoprotein E-containing lipoproteins in the high density lipoprotein size range: focus on pre-beta1-LpE, pre-beta2-LpE, and alpha-LpE","volume":"38","author":"Krimbou","year":"1997","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.rbmo.2011.10.010_b0120","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1194\/jlr.M200273-JLR200","article-title":"Structural and functional properties of human plasma high density-sized lipoprotein containing only apoE particles","volume":"44","author":"Krimbou","year":"2003","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.rbmo.2011.10.010_b0130","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1080\/00016340902859315","article-title":"Oxidative stress but not endothelial dysfunction exists in non-obese, young group of patients with polycystic ovary syndrome","volume":"88","author":"Kuscu","year":"2009","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.rbmo.2011.10.010_b0135","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1042\/BJ20061048","article-title":"Pathway of biogenesis of apolipoprotein E-containing HDL in vivo with the participation of ABCA1 and LCAT","volume":"403","author":"Kypreos","year":"2007","journal-title":"Biochem. J."},{"key":"10.1016\/j.rbmo.2011.10.010_b0140","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1210\/jc.84.1.165","article-title":"Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women","volume":"84","author":"Legro","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.rbmo.2011.10.010_b0145","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.rbmo.2011.10.010_b0150","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/humupd\/dmp008","article-title":"Metabolic features of the reproductive phenotypes of polycystic ovary syndrome","volume":"15","author":"Moran","year":"2009","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.rbmo.2011.10.010_b0255","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S0022-2275(20)33461-1","article-title":"Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1","volume":"41","author":"Navab","year":"2000","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.rbmo.2011.10.010_b0155","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1194\/jlr.R400001-JLR200","article-title":"The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL","volume":"45","author":"Navab","year":"2004","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.rbmo.2011.10.010_b0165","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/jcla.1031","article-title":"Direct measurement of HDL cholesterol: method eliminating apolipoprotein E-rich particles","volume":"15","author":"Okada","year":"2001","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.rbmo.2011.10.010_b0170","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/S0015-0282(02)03111-4","article-title":"Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus","volume":"77","author":"Ovalle","year":"2002","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2011.10.010_b0175","doi-asserted-by":"crossref","first-page":"4816","DOI":"10.1074\/jbc.274.8.4816","article-title":"Apolipoprotein E containing high density lipoprotein stimulates endothelial production of heparan sulfate rich in biologically active heparin-like domains. A potential mechanism for the anti-atherogenic actions of vascular apolipoprotein e","volume":"274","author":"Paka","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.rbmo.2011.10.010_b0180","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s00125-003-1097-5","article-title":"IRS1 degradation and increased serine phosphorylation cannot predict the degree of metabolic insulin resistance induced by oxidative stress","volume":"46","author":"Potashnik","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/j.rbmo.2011.10.010_b0185","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.atherosclerosis.2008.09.010","article-title":"Polycystic ovary syndrome is associated with severe platelet and endothelial dysfunction in both obese and lean subjects","volume":"204","author":"Rajendran","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.rbmo.2011.10.010_b0190","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0015-0282(16)57728-0","article-title":"Ultrasound assessment of ovarian stroma hypertrophy in hyperandrogenism and ovulation disorders: visual analysis versus computerized quantification","volume":"64","author":"Robert","year":"1995","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2011.10.010_b0195","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1194\/jlr.M500525-JLR200","article-title":"Regulation of reconstituted high density lipoprotein structure and remodeling by apolipoprotein E","volume":"47","author":"Rye","year":"2006","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.rbmo.2011.10.010_b0200","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0009-9120(01)00245-4","article-title":"Oxidative stress in polycystic ovary syndrome and its contribution to the risk of cardiovascular disease","volume":"34","author":"Sabuncu","year":"2001","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.rbmo.2011.10.010_b0205","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1210\/jc.2007-0425","volume":"93","author":"Shaw","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.rbmo.2011.10.010_b0210","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.fertnstert.2007.01.032","article-title":"Risk of metabolic complications in the new PCOS phenotypes based on the Rotterdam criteria","volume":"88","author":"Shroff","year":"2007","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2011.10.010_b0215","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0168-8227(00)00152-2","article-title":"Homeostasis model assessment in a population with mixed ethnicity: the 1992 Singapore National Health Survey","volume":"49","author":"Tai","year":"2000","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.rbmo.2011.10.010_b0220","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1161\/01.ATV.20.11.2414","article-title":"Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women","volume":"20","author":"Talbott","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.rbmo.2011.10.010_b0225","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","year":"2004","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2011.10.010_b0230","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S1567-5688(02)00045-4","article-title":"Inflammation, bioactive lipids and atherosclerosis: potential roles of a lipoprotein-associated phospholipase A2, platelet activating factor-acetylhydrolase","volume":"3","author":"Tselepis","year":"2002","journal-title":"Atheroscler. Suppl."},{"key":"10.1016\/j.rbmo.2011.10.010_b0235","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1210\/jc.2007-1756","article-title":"A more atherogenic serum lipoprotein profile is present in women with polycystic ovary syndrome: a case-control study","volume":"93","author":"Valkenburg","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.rbmo.2011.10.010_b0240","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0009-8981(93)90046-7","article-title":"Alterations in the concentration of an apolipoprotein E-containing subfraction of plasma high density lipoprotein in coronary heart disease","volume":"220","author":"Wilson","year":"1993","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.rbmo.2011.10.010_b0245","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/89986","article-title":"High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase","volume":"7","author":"Yuhanna","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.rbmo.2011.10.010_b0250","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1161\/01.ATV.0000143389.00252.bc","article-title":"Inhibition of cholesteryl ester transfer protein activity by JTT-705 increases apolipoprotein E-containing high-density lipoprotein and favorably affects the function and enzyme composition of high-density lipoprotein in rabbits","volume":"24","author":"Zhang","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."}],"container-title":["Reproductive BioMedicine Online"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648311005426?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648311005426?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T03:45:57Z","timestamp":1639367157000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472648311005426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S1472648311005426"],"URL":"https:\/\/doi.org\/10.1016\/j.rbmo.2011.10.010","relation":{},"ISSN":["1472-6483"],"issn-type":[{"value":"1472-6483","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}